Jefferies Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Buy
+11,100
New +$107K ﹤0.01% 1497
2024
Q4
– Sell
-25,001
Closed -$369K – 1747
2024
Q3
$369K Buy
+25,001
New +$391K ﹤0.01% 1064
2024
Q1
– Sell
-15,423
Closed -$250K – 1883
2023
Q4
$250K Buy
+15,423
New +$252K ﹤0.01% 1426

Other funds holding NEO

Jefferies Financial Group's NEO Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in NeoGenomics (NEO) in Q2 2026: 11,100 shares worth $162K. The stake represents ﹤0.01% of the portfolio and ranks #1497 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in NEO as recently as Q3 2024.

Jefferies Financial Group first reported a position in NEO in Q4 2023 and has held it in 3 quarters since. The position peaked at $369K in Q3 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Jefferies Financial Group held 11,100 shares of NeoGenomics worth $162K as of Q2 2026.
  • NeoGenomics was a new Jefferies Financial Group position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1497 holding.
  • Jefferies Financial Group first reported a position in NeoGenomics in Q4 2023 and has held it in 3 quarters since.
  • Jefferies Financial Group's NeoGenomics position peaked at $369K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.